statements

Zota Health Care Ltd.

NSE: ZOTA

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,242.70-30.4 (-2.39%)

23 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Zota Health Care Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	38.14	43.91	50.11	56.46	64.73	71.58	77.85	85.63	95.11	106.79	131.19	139.96	180.49	292.97	538.66	608.68
Cost of Operating Revenue	27.66	31.70	35.41	38.31	43.37	46.20	51.97	60.71	70.65	78.92	92.98	96.79	120.24	186.82	304.51	330.40
Gross Profit	10.48	12.21	14.70	18.15	21.36	25.38	25.88	24.92	24.47	27.87	38.21	43.17	60.25	106.15	234.15	278.28
Gross Margin	27.5	27.8	29.3	32.2	33.0	35.5	33.2	29.1	25.7	26.1	29.1	30.8	33.4	36.2	43.5	45.7
Total Operating Expenses	34.70	39.36	44.80	49.49	56.40	62.59	67.89	79.28	92.69	109.33	120.07	144.58	193.02	341.90	602.57	701.21
Operating Profit	3.44	4.55	5.31	6.97	8.33	8.99	9.96	6.35	2.42	-2.54	11.13	-4.62	-12.53	-48.92	-63.91	-92.54
Operating Margin	9.0	10.4	10.6	12.3	12.9	12.6	12.8	7.4	2.5	-2.4	8.5	-3.3	-6.9	-16.7	-11.9	-15.2
Financing Income/(Expense) - Net	-0.51	-0.79	-0.71	-0.66	-0.68	-0.68	-0.12	1.37	1.33	0.71	1.18	-1.44	-4.58	-8.82	-9.95	-20.47
Profit before Taxes	2.96	3.79	4.70	6.32	7.72	8.36	11.34	7.86	3.86	-0.37	12.43	-4.69	-16.16	-57.64	-79.84	-110.41
Income Taxes	0.98	1.24	1.57	2.06	2.61	2.82	4.07	2.31	1.12	-0.16	3.53	1.08	-1.82	-0.91	-5.76	-6.16
Profit after Tax	1.98	2.55	3.13	4.26	5.11	5.54	7.27	5.55	2.74	-0.21	8.91	-5.77	-14.35	-56.40	-73.94	-103.18
PAT Margin	5.2	5.8	6.2	7.5	7.9	7.7	9.3	6.5	2.9	-0.2	6.8	-4.1	-7.9	-19.3	-13.7	-17.0
EPS - Basic - ex Extraordinary Items	0.81	1.04	1.27	1.73	2.54	2.76	3.02	2.26	1.12	-0.09	3.58	-2.29	-5.59	-19.06	-22.46	-30.88
EPS - Diluted - ex Extraordinary Items	0.81	1.04	1.27	1.73	2.54	2.76	3.02	2.26	1.12	-0.09	3.58	-2.29	-5.59	-19.06	-22.46	-30.88
EBIT	3.44	4.55	5.31	6.97	8.33	8.99	9.96	6.35	2.42	-2.54	11.13	-4.62	-12.53	-48.92	-63.91	-92.54
EBITDA	4.83	5.90	6.52	8.48	9.57	10.34	10.90	7.74	4.52	0.62	14.80	7.34	7.55	-5.72	18.54	2.99
EBITDA Margin	12.7	13.4	13.0	15.0	14.8	14.5	14.0	9.0	4.7	0.6	11.3	5.2	4.2	-2.0	3.4	0.5

Balance Sheet

Abridged

Understanding Balance Sheet

Zota Health Care Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	PR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	18	20	24	30	35	44	56	62	59	61	77	84	112	184	457
Long-Term Investments	0	0	0	0	0	0	26	16	14	10	33	8	5	54	264
Property Plant & Equipment - Net	10	9	9	8	8	7	7	8	8	8	24	61	103	187	366
Total Non-Current Assets	10	9	9	8	9	9	36	27	30	24	62	74	117	255	674
Total Assets	28	29	33	38	44	54	92	90	88	85	139	158	228	439	1,131
Total Current Liabilities	12	12	14	18	18	24	21	20	19	18	36	41	74	101	237
Long Term Debt	3	3	3	2	2	2	-	-	-	-	12	36	63	108	190
Total Non-Current Liabilities	3	3	4	2	3	3	1	1	1	1	14	37	65	111	198
Total Liabilities	16	16	18	20	21	27	22	21	20	19	49	78	138	212	435
Total Shareholders' Equity	13	14	16	18	23	27	70	69	69	66	90	80	90	224	693
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	3	3
Total Equity	13	14	16	18	23	27	70	69	69	66	90	80	90	227	696
Total Liabilities & Equity	28	29	33	38	44	54	92	90	88	85	139	158	228	439	1,131

Cash Flow

Abridged

Understanding Cash Flow Statement

Zota Health Care Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	3.73	3.91	4.33	5.63	6.26	6.54	8.26	6.93	4.86	1.71	12.37	4.59	2.74	-17.23	-5.95
Working Capital - Increase/(Decrease)	0.76	-1.90	-1.98	-1.96	-2.32	-3.85	-11.32	-8.79	1.72	-1.91	1.97	-8.29	-11.98	-39.99	-86.94
Net CF from Operating Activities	4.49	2.01	2.35	3.67	3.93	2.70	-3.07	-1.86	6.58	-0.20	14.34	-3.70	-9.24	-57.21	-92.89
Capital Expenditures - Net	3.44	0.68	1.10	0.72	1.35	1.91	1.32	3.12	6.18	0.84	3.25	11.36	16.61	45.97	126.43
Net CF from Investing Activities	-3.44	-0.68	-1.11	-0.72	-1.36	-1.82	-27.66	7.42	-4.58	3.12	-27.92	13.93	-13.84	-95.62	-335.96
Dividends Paid - Cash - Total	-	-	-	-	-	-	3.53	5.26	2.46	2.46	2.52	3.77	2.58	2.74	3.06
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	-	3.18	0.01	0.10	-	2.50	-	5.96	40.62	-37.04
Debt - LT & ST - Issuance/(Retirement) - Total	-0.09	0.07	0.17	-1.20	0.00	0.23	-2.46	-	-	0.10	-0.51	-5.91	4.37	-30.79	-18.84
Net Cash Flow from Financing Activities	-1.25	-1.33	-1.22	-2.93	-1.98	-1.50	33.05	-6.33	-2.86	-2.41	14.53	-11.41	22.97	155.45	520.80
Free Cash Flow to Equity	0.96	1.40	1.42	1.75	2.59	1.02	-6.84	-4.98	0.40	-0.94	10.58	-20.98	-21.48	-133.97	-238.16
Free Operating CF net dividend	0.90	1.34	1.24	2.95	2.55	0.78	-7.91	-10.25	-2.05	-4.58	8.58	-19.98	-28.53	-105.93	-222.38
Free Operating CF	0.90	1.34	1.24	2.95	2.55	0.78	-4.38	-4.98	0.40	-2.13	11.09	-16.20	-25.95	-103.19	-219.32

Business Segment Analysis

FY End:

Mar 26

Zota Health Care Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Manufacturing and marketing of pharmaceutical products (100.0%)₹ 126.43 Cr

Revenue / Sales

Manufacturing and marketing of pharmaceutical products (100.0%)₹ 538.66 Cr

Assets

Manufacturing and marketing of pharmaceutical products (100.0%)₹ 1,131.05 Cr

Operating Income

Manufacturing and marketing of pharmaceutical products (100.0%)₹ -63.91 Cr

Regional Segment Analysis

Zota Health Care Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Zota Health Care Ltd.

Historical Segment Analysis

Track how Zota Health Care Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Manufacturing and marketing of pharmaceutical products	6	2	3	12	17	46	126

Frequently Asked Questions

What is the revenue of Zota Health Care Ltd.?

The latest trailing twelve month revenue of Zota Health Care Ltd. is ₹ 608.68 Cr, reflecting a 1-year growth of 78.89% and a 3-year CAGR of 59.71%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Zota Health Care Ltd.?

The latest trailing twelve month net profit (PAT) of Zota Health Care Ltd. is ₹ -103.18 Cr, with a 3-year earnings CAGR of -116.62%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Zota Health Care Ltd.?

The trailing twelve month EBITDA of Zota Health Care Ltd. is approximately ₹ -92.54 Cr (based on an operating margin of -15.20%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Zota Health Care Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Zota Health Care Ltd. is -31.41. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Zota Health Care Ltd.?

The debt-to-equity ratio of Zota Health Care Ltd. stands at 0.39. The interest coverage ratio is -4.52x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Zota Health Care Ltd.?

The estimated book value per share of Zota Health Care Ltd. is 200.24 (derived from a P/B ratio of 6.21 and market price of ₹ 1,242.70), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Zota Health Care Ltd.?

The trailing twelve month operating cash flow of Zota Health Care Ltd. is ₹ -92.89 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Zota Health Care Ltd. report consolidated or standalone financials?

Zota Health Care Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.